All posts by imreal

Advancements Hosted by Ted Danson to Explore Innovations in Corona Virus and other Pathogen Removal and Protection


News Image

“A building can typically be treated in one day and provide safety for anyone worried about getting the virus,” said Will Mensch, producer for DMG Productions and the Advancements series. “We look forward to exploring how this technology can help slow further spread of the coronavirus…”

Advancements with Ted Danson will educate about the current coronavirus pandemic and how innovative pathogen removal technologies are working to destroy the virus on contact. Check local listings for more information.

An upcoming segment of Advancements will focus on the Pure Maintenance patented dry fog system and its ability to destroy the coronavirus on contact. Viewers will learn about the EverPURE protectant, which protects surfaces for up to 90 days from all viruses, including COVID-19.

One difficult aspect of a new virus forming is the lack of available specimens for testing. Preliminary tests have shown the virus is fairly easy to kill on a surface, when an oxidizer like Pure Maintenance is applied. Spectators will see how as an enveloped virus, the coronavirus can be killed on contact with InstaPURE or EverPURE and requires very little dwell time.

“We are excited to partner with CNBC and Advancements television to display our patented dry fog technology and the capabilities it has to help Americans all over the country,” said Brandon Adams, CEO of Pure Maintenance.

“A building can typically be treated in one day and provide safety for anyone worried about getting the virus,” said Will Mensch, producer for DMG Productions and the Advancements series. “We look forward to exploring how this technology can help slow further spread of the coronavirus for people throughout the world.”

About Pure Maintenance:

Pure Maintenance is a demolition free mold and pathogen removal company. Using the patented Dry Fog technology, Pure Maintenance can fill up the entire volume of space within a building with an EPA approved sterilant that removes bacteria, viruses, and mold from surfaces and air. It denatures spores and removes airborne pathogens, in furniture, fabrics, air ducts, and behind walls.

For more information, visit: http://www.puremaintenance.com. If you would like information on getting your home, office, school, or facility treated for coronavirus call 801-513-3364.

About Advancements and DMG Productions:

The Advancements series is an information-based educational show targeting recent advances across a number of industries and economies. Featuring state-of-the-art solutions and important issues facing today’s consumers and business professionals, Advancements focuses on cutting-edge developments, and brings this information to the public with the vision to enlighten about how technology and innovation continue to transform our world.

Backed by experts in various fields, DMG Productions is dedicated to education and advancement, and to consistently producing commercial-free, educational programming on which both viewers and networks depend.

For more info, please visit: AdvancementsTV.com or call Will Mensch at 866-496-4065.

Share article on social media or email:

Local Businesses Rally to Meet Community Needs During the Coronavirus


News Image

“As a consumer, when you purchase from a mom and pop – such as your neighborhood coffee shop – you’re helping pay the barista you chat with every morning,” said Michael Plummer, Our Town America’s President.

As Americans across the country self-quarantine to minimize the spread of Coronavirus (COVID-19), local small business owners are rallying to serve their communities. They’re doing their part to protect the health and safety of their employees and customers while remaining available to provide products and services people need.

In this time of uncertainty, Our Town America, a national new mover marketing franchise that helps local businesses create and maintain relationships with customers, salutes these business owners and wants to remind all Americans that it’s more important than ever to shop local – whether virtually, curbside or online – and support businesses that are the backbone of the local economy.

“As a consumer, when you purchase from a mom and pop – such as your neighborhood coffee shop – you’re helping pay the barista you chat with every morning,” said Michael Plummer, Our Town America’s President. “You’re helping put food on their children’s plate and helping fulfill their young daughter’s dream of going to college. You are keeping your local community alive and thriving.”

Our Town America franchise owners are small business owners themselves, so they understand the importance of shopping local and the direct effects it has on a business and its employees – especially during a time like this.

“As Americans, we’re tough and resilient, especially in times of crisis,” said Plummer. “The Coronavirus is real and scary, but it’s not permanent, and we will get through this. In addition to self-quarantining to stop the virus’ spread, we ask all Americans to continue buying local to help small business owners and the employees who depend on them.”

There are countless examples of businesses that have adjusted on the fly to continue serving the public while doing everything possible to practice social distancing. These include, but are not limited to:


  • Restaurants offering curbside service and delivery drops at front doors
  • Doctors and veterinarians offering virtual appointments while remaining on call to treat more serious conditions in person
  • Gyms and trainers sharing home-based cardio and strength workouts
  • Commercial and residential cleaning companies working around the clock to disinfect buildings using EPA/CDC recommended products specific to Coronavirus
  • Grocery stores and hotels operated by employees wearing gloves who are making it as safe as possible to access necessary food and accommodations

“The method of delivery may be different – from curbside service to virtual appointments – but it’s imperative to support the small businesses doing everything they can to continue serving their local community,” said Plummer. “There are more than 28 million small businesses in the country and all of them could use a little love during this tough time. Please do everything you can to support local businesses so they can keep their employees and continue serving the community you call home.”

For more information on Our Town America, please visit https://www.ourtownamerica.com/.

For more information on the Our Town America franchise opportunity, please visit https://www.newmoverfranchise.com/.

About Our Town America

For over 48 years, Our Town America has been providing new movers with traditional hospitality by mailing warm housewarming gifts from local neighborhood businesses in a premium welcome package. Since the company started franchising in 2005, Our Town America has consistently been placed in the Franchise Top 50, ranking top in their category for franchisee satisfaction.

Our Town America’s dedication to the “sponsor exclusivity” concept, meaning Our Town America will only recommend one of each business type in any specific zip code within its welcome packages, has been one of the key catalysts for the company’s long-term success. In addition, sponsors consistently rave about other unique aspects of the new mover marketing program – such as their ability to reach a brand-new audience of impressionable new movers each month and the insightful data/metrics delivered by Our Town America’s innovative pinpoint tracking system.

Due in large part to Our Town America’s devotion to those concepts, thousands of satisfied business owners throughout the United States attest to the success and effectiveness of the program. Additionally, dozens of locally owned franchisees validate Our Town America’s concept as a viable business opportunity.

It is Our Town America’s mission to assist new movers adjusting to their community, help businesses gain new and loyal customers and provide franchisees with an excellent opportunity. The eight million households who receive Our Town America’s welcome packages each year prove that Our Town America is committed to following through on that mission statement.

For more information, visit the Our Town America website at https://www.ourtownamerica.com or call 1-800-497-8360.

Media Contacts:

Graham Chapman                                 Brittany Johnson

919-459-8157                                     800-497-8360 x229

gchapman@919marketing.com                     bjohnson@ourtownamerica.com

Share article on social media or email:

OU Health Sciences Center Partners With Pure MHC on COVID-19 Vaccine Project


Pure MHC has obtained the actual COVID-19 virus, will infect cells and look for the targets on the infected cells.  Pure MHC will then use those targets to either develop a vaccine or to directly target them with something like monoclonal antibodies.

Curtis McMurtrey, Ph.D., Director of Immuno-Proteomics at Pure MHC

With OU, we are acquiring the actual COVID-19 virus, and we will infect cells and look for the targets on the infected cells. We will use those targets to either develop a vaccine or to directly target them with something like monoclonal antibodies.

OUHSC and Pure MHC have launched a research collaboration to work toward the development of a vaccine for the COVID-19 virus. The scientific team is led by William Hildebrand, Ph.D., whose expertise is helping the body’s protective immune cells target and kill virus-infected cells. He will be working with Pure MHC, part of a family of biotechnology companies formed, funded and managed by Austin, TX based Emergent Technologies, Inc. (ETI). Approximately 20 years ago, ETI commercialized and advanced Hildebrand’s and others’ research to develop breakthrough drugs and therapies. This partnership represents a unique collaboration between researchers in a university setting and a company with the scientific expertise and investment to further the project.

Hildebrand’s research career has focused on a crucial component of vaccine development: creating targets that help the immune system’s T-cells find and kill virus-infected cells. Because COVID-19 is an entirely new virus, the body’s immune system has not been trained to recognize it. Hildebrand’s research discoveries could provide a target for a potential vaccine.

“The body’s T-cells are able to distinguish virus-infected cells from healthy cells and, for the most part, they are able to eliminate infected cells without harming healthy cells,” Hildebrand said. “However, with COVID-19, our T-cells have not been prepared to recognize this coronavirus, and the disease is able to get a foothold before our immune system is able to catch up to it. What we want to do is to prepare our cells in advance, just as the body uses the flu vaccine – it gets your immune system ready to target the flu. Our role is to identify the targets that mark COVID-19, and then steer the T-cells to those targets using a vaccine.”

Hildebrand has been working on this type of target discovery technology for nearly three decades. He successfully discovered a target that allows T-cells to protect against the West Nile Virus, as well as a cancer target that allows T-cells to kill the malignant cells in melanoma. Now his charge is to discover the target for COVID-19.

For that work, the OU Health Sciences Center brings an important resource to the collaboration with Pure MHC: a Biosafety Laboratory-3, one of the safest and most specialized laboratories for working with infectious diseases. The laboratory ensures a high level of protection for research personnel because they will be working with the live virus.

“With OU, we are acquiring the actual COVID-19 virus, and we will infect cells and look for the targets on the infected cells,” said Curtis McMurtrey, Ph.D., Director of Immuno-Proteomics for Pure MHC and a graduate of the OU Health Sciences Center. “We will use those targets to either develop a vaccine or to directly target them with something like monoclonal antibodies.”

“Because the OU Health Sciences Center and Pure MHC have been working together on similar projects for over 20 years, they are uniquely positioned to quickly develop a target for COVID-19”, said Tommy Harlan, founder, chairman and CEO of Emergent Technologies, Inc., the technology commercialization company that manages Pure MHC. Harlan said he founded his company specifically to find and commercialize early-stage discoveries so they can positively affect human health and disease.

“After 20 years of working with Dr. Hildebrand and the OU Health Sciences Center, and through our commercial entity Pure MHC, we are positioned to pursue this discovery project very quickly at a time when speed is important,” Harlan said. “It all lines up at a time when society needs help with this devastating disease.”

Such partnerships are key to the university moving its discoveries into the marketplace, said James Tomasek, Ph.D., Vice President for Research at the OU Health Sciences Center. In 1998, the state of Oklahoma passed two state questions that allowed academic research to be transformed into start-up biotech companies. Tomasek, along with the university’s Office of Technology Commercialization, assist researchers in preparing their science for outside licensing and investment.

“The partnership between the OU Health Sciences Center and Pure MHC, a company developed from OU Health Sciences Center technology and housed at University Research Park in Oklahoma City, demonstrates how discoveries can be taken from the lab to the marketplace to address critical healthcare needs, like developing a vaccine for COVID-19,” Tomasek said.

###

OU HEALTH SCIENCES CENTER

One of nation’s few academic health centers with seven professional colleges — Allied Health, Dentistry, Medicine, Nursing, Pharmacy, Public Health and Graduate Studies — the University of Oklahoma Health Sciences Center serves approximately 4,000 students in more than 70 undergraduate and graduate degree programs on campuses in Oklahoma City and Tulsa. For more information, visit http://www.ouhsc.com.

OU MEDICINE

OU Medicine — along with its academic partner, the University of Oklahoma Health Sciences Center — is the state’s only comprehensive academic health system of hospitals, clinics and centers of excellence. With 11,000 employees and more than 1,300 physicians and advanced practice providers, OU Medicine is home to Oklahoma’s largest physician network with a complete range of specialty care. OU Medicine serves Oklahoma and the region with the state’s only freestanding children’s hospital, the only National Cancer Institute-Designated Stephenson Cancer Center and Oklahoma’s flagship hospital, which serves as the state’s only Level 1 trauma center. OU Medicine is the No. 1 ranked hospital system in Oklahoma, and its oncology program at Stephenson Cancer Center and OU Medical Center ranked in the Top 50 in the nation, in the 2019-2020 rankings released by U.S. News & World Report. OU Medicine was also ranked by U.S. News & World Report as high performing in four specialties: Ophthalmology in partnership with Dean McGee Eye Institute, Colon Surgery, COPD and Congestive Heart Failure. OU Medicine’s mission is to lead healthcare in patient care, education and research. To learn more, visit http://www.oumedicine.com.

Pure MHC

Pure MHC, LLC is a platform technology company funded and managed by Emergent Technologies, Inc. with expertise in disease-specific target identification and validation as well as immunotherapeutic drug development for cancer, infectious and autoimmune diseases and allergy. The Pure MHC target discovery technology was developed by Chief Scientist William Hildebrand, Ph.D., of the University of Oklahoma Health Sciences Center. For more information, visit http://www.puremhc.com.

Emergent Technologies

Emergent Technologies, Inc. is an innovation solutions and technology commercialization leader headquartered in Austin, Texas. For more information visit http://www.etibio.com.

SanitGrasp Internationally Patented Hands Free Restroom Door Handle is in High Demand


News Image

Our patented public hands free door handle – The SanitGrasp – is exploding in sales. We are prepared to help the health of all public facilities” stated Mathew Fulkerson owner of the SanitGrasp patents.

SanitGrasp, the internationally patented hands-free door handle, is being recognized as the door handle that best satisfies health and safety concerns that have recently been raised due to the current World Wide health concerns. This door handle is in the shape of a “J”, thereby allowing a person to open a door with their closed fist or wrist. The SanitGrasp is designed for all public facilities allowing people to avoid germs on the public restroom door pull handle.

The SanitGrasp has been identified as a major improvement to public and private facilities throughout the US, since 2005. However, due to the recent developments the SanitGrasp is in significant demand. “We have received a substantial increase in orders. In the initial years we would see a spike due to certain strains of Influenza, but due to much hard work we are a specified product within many facilities and we have been able manage our demand. But this is much different we have been slammed with orders for corporations, Government offices, and public facilities.” stated Matthew Fulkerson, inventor of the SanitGrasp and owner of Fulkerson, LLC.

The SanitGrasp was engineered to easily remove an existing door pull handle and use the same screw holes to add the SanitGrasp in place of the old door handle. What a simple solution to the old problem, how do I exit the restroom without touching that nasty door handle.

Additional information is available at http://www.sanitgrasp.com or by contacting Fulkerson, LLC at 800-351-6435.

Share article on social media or email:

Singapore-Based Ramco Systems’ Innovation Lab Unveils Advanced Facial Attendance System Embedded with Temperature Recording


The launch of the advanced facial attendance system by Ramco Systems is timely, given global concerns over pandemic threats…

The Ramco Innovation Lab in Singapore unveiled today an advanced facial recognition based Time & Attendance System – RamcoGEEK, embedded with Temperature recording and IoT sensor doors to enable organizations move towards a ‘Touch-less’ attendance and workplace access, in the wake of the COVID-19 outbreak.

COVID-19 has brought the focus back on ‘Hygiene’. With the Virus outbreak now reaching over 110+ countries and affecting more than 150,000 people; the concern around employee safety and health has gained paramount importance.

The Ramco Innovation Lab unveiled the innovation which drew upon its own facial recognition-based attendance system deployed across multiple organizations, globally and combined it with a thermal imaging device for temperature measurement as well as other associated software. This enables organizations to track staff or visitors with high temperatures that may indicate infection and build in operating procedures to avoid further contaminations caused by finger/thumb based biometric scanners. Ramco Systems, headquartered in Chennai, India, is a global enterprise software specialist which has pioneered many HR-related innovations.

RamcoGEEK for Attendance with Temperature capturing can:

  • Detect and match the faces of staff members and mark their attendance along with temperature; where facial based attendance is a privacy concern, enterprises can replace it with Voice to register access
  • System is linked to an IoT sensor powered door which can restrict access in case the temperature is higher than normal and auto apply leave on behalf of the employee
  • Communicate the information to HR and management in real-time
  • Track the movements of a high-temperature staff in the workplace

RamcoGEEK for Visitors can:

  • Send notifications when RamcoGEEK encounters a person with a very high temperature to the Facility Manager / Facility Admin
  • Track the movement of that person within that premise

RamcoGEEK for Contact Tracing can:

  • Send notifications / Alerts to all those employees, customers, vendors and others interacted with in-person, in the event any person develops COVID-19 symptoms/ diagnosed
  • The Track and Trace system is capable of reading Outlook calendar, Credit card spend data, trip details from Uber Lyft and Grab (subject to permission) to identify people met, Hotels stayed, Flights taken, Taxi drivers used and use this information to help identify employees at risk.
  • Reverse tracing can also be initiated based on data around positive COVID-19 cases from external environment – for instance, a positive case of COVID-19 at a restaurant can alert all employees who have dined at the restaurant to be quarantined (based on bills raised)
  • Help HR set up its own procedures to seek recent movements of the affected person, based on the information provided by the attendance system
  • This piece of software could be leveraged provided RamcoGEEK could get access to the data specified above. And these data could be stored in organization’s premises or could leverage Ramco’s cloud for storing the same.
  • Support authorities with essential information, if needed (e.g., to facilitate contact-tracing)

“We have a major global health pandemic that has affected many. The spread of the disease has brought the focus back on Hygiene and Health of Employees. We built this application to help better address a crisis through technology. Robust containment through a robust attendance and access system with zero contact and temperature measurement can be key to avoid easy spread of the virus that may take place with Biometric access system” said Mr. Virender Aggarwal, CEO – Ramco Systems.

“The launch of the advanced facial attendance system by Ramco Systems is timely, given global concerns over pandemic threats. We continue to see companies undertake a spectrum of innovation activities from Singapore, as they develop new products and solutions to address the needs and challenges of today,” said Ms. Junie Fo, Director, Investment Facilitation, Singapore Economic Development Board (EDB).

Complete with chatbots, voice, and facial recognition-based workforce management, organizations can deploy Ramco HR with Global Payroll on-cloud, on premise or leverage as a managed service. The multi-tenant architecture with embedded intelligence and device agnostics features now serves more than 500+ clients worldwide. With innovative concepts of Artificial Intelligence & Machine learning, Context-sensitive Pop-ups and Chatbots to carry out self-service, and Voice based HR transactions on Google Assistant & Alexa, Ramco has been setting the benchmark for Innovation in this segment. With statutory compliance across 45+ countries covering ANZ, Asia (including Japan & China), Middle-East & Africa, UK and Ireland, Ramco’s Global Payroll is available in English, Japanese, Mandarin, Bahasa, Thai, Malay, Arabic among others.

If you would like to explore the solution, visit: https://campaigns.ramco.com/ramco-time-and-attendance-with-temperature-recording-system.

About Ramco Systems:

Ramco is a next-gen enterprise software player disrupting the market with its multi-tenant cloud and mobile-based enterprise software in HR and Global Payroll, ERP and M&E MRO for Aviation. Part of the USD 1 billion Ramco Group, Ramco Systems focuses on Innovation and Culture to differentiate itself in the marketplace. On the Innovation front, Ramco has been focusing on moving towards Active ERP leveraging Artificial Intelligence and Machine Learning by building features such as Talk It – which allows transactions to be carried out by simple voice commands, Bot it – which allows users to complete transactions using natural conversations; Mail It – transact with the application by just sending an email; HUB It – a one screen does it all concept built to address all activities of a user; Thumb It – mobility where the system presents users with option to choose rather than type values and Prompt It – a cognitive ability which will let the system complete the transaction and prompts the user for approval.

With 1900+ employees spread across 24 offices, globally, Ramco follows a flat and open culture where employees are encouraged to share knowledge and grow. No Hierarchies, Cabin-less Offices, Respect work and not titles, among others are what makes the team say, Thank God it’s Monday!

Only APAC vendor to be positioned in Gartner Magic Quadrant for ERP, Cloud Financials, Cloud HCM and EAM;

Leader in NelsonHall’s NEAT Matrix for Next Gen Payroll Services;

Winner Global Payroll Transformation Project of the Year – 2019 by Global Payroll Association;

Winner of 2018 ISG Paragon Awards Australia, for ‘Best Imagination’ Award

For more information, please visit http://www.ramco.com/time-and-attendance.

Follow Ramco on Twitter @ramcosystems / @ramcohcm and stay tuned to http://blogs.ramco.com.

For further information, contact:

Vinitha Ramani

+91 44 6653 4204

vinitharamani@ramco.com

Share article on social media or email:



NeoTract Designates Dr. Craig Smith as UroLift® Center of Excellence


News Image

“We are proud to name Dr. Craig Smith as a UroLift Center of Excellence and provider of care for men with enlarged prostate symptoms using the UroLift System treatment,” said Dave Amerson

NeoTract, a wholly owned subsidiary of Teleflex Incorporated (NYSE:TFX) focused on addressing unmet needs in the field of urology, today announced that Craig Smith, M.D., DuPage Medical Group in Chicago, IL, has been designated as a UroLift® Center of Excellence. The designation recognizes that Dr. Smith has achieved a high level of training and experience with the UroLift® System and demonstrated a commitment to exemplary care for men suffering from symptoms associated with Benign Prostatic Hyperplasia (BPH), also known as enlarged prostate.

Recommended for the treatment of BPH in both the American Urological Association and European Association of Urology clinical guidelines, the FDA-cleared Prostatic Urethral Lift procedure using the UroLift System is a proven, minimally invasive technology for treating lower urinary tract symptoms due to BPH. The UroLift permanent implants, delivered during a transurethral outpatient procedure, relieve prostate obstruction and open the urethra directly without cutting, heating, or removing prostate tissue.

The UroLift Center of Excellence program is designed to highlight urologists who are committed to educating their patients on BPH and the UroLift System as a treatment option and consistently seek to deliver excellent patient outcomes and experiences.

“We are proud to name Dr. Craig Smith as a UroLift Center of Excellence and provider of care for men with enlarged prostate symptoms using the UroLift System treatment,” said Dave Amerson, president of the Teleflex Interventional Urology business unit. “The UroLift System is a safe and effective treatment that allows physicians to treat men in-office under local anesthesia, so they can experience lasting symptom relief within days after receiving treatment.”

Over 40 million men in the United States are affected by BPH, a condition that occurs when the prostate gland that surrounds the male urethra becomes enlarged with advancing age and begins to obstruct the urinary system. Symptoms of BPH often include interrupted sleep and urinary problems and can cause loss of productivity, depression and decreased quality of life.

Medication is often the first-line therapy for enlarged prostate, but relief can be inadequate and temporary. Side effects of medication treatment can include sexual dysfunction, dizziness and headaches, prompting many patients to quit using the drugs. For these patients, the classic alternative is surgery that cuts, heats or removes prostate tissue to open the blocked urethra. While current surgical options can be very effective in relieving symptoms, they can also leave patients with permanent side effects such as urinary incontinence, erectile dysfunction, and retrograde ejaculation.

About the UroLift® System

The FDA-cleared UroLift System is a proven, minimally invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia (BPH). The UroLift permanent implants, delivered during a minimally invasive transurethral outpatient procedure, relieve prostate obstruction and open the urethra directly without cutting, heating, or removing prostate tissue. Clinical data from a pivotal 206-patient randomized controlled study showed that patients with enlarged prostate receiving UroLift implants reported rapid and durable symptomatic and urinary flow rate improvement without compromising sexual function*1,2. Patients also experienced a significant improvement in quality of life. Over 100,000 men have been treated with the UroLift System in the U.S. Most common adverse events reported include hematuria, dysuria, micturition urgency, pelvic pain, and urge incontinence. Most symptoms were mild to moderate in severity and resolved within two to four weeks after the procedure. The Prostatic Urethral Lift procedure using the UroLift System is recommended for the treatment of BPH in both the American Urological Association and European Association of Urology clinical guidelines. The UroLift System is available in the U.S., Europe, Australia, Canada, Mexico and South Korea. Learn more at http://www.UroLift.com.

About NeoTract | Teleflex Interventional Urology

A wholly owned subsidiary of Teleflex Incorporated, the Interventional Urology Business Unit is dedicated to developing innovative, minimally invasive and clinically effective devices that address unmet needs in the field of urology. Our initial focus is on improving the standard of care for patients with BPH using the UroLift System, a minimally invasive permanent implant system that treats symptoms while preserving normal sexual function*1,2. Learn more at http://www.NeoTract.com.

About Teleflex Incorporated

Teleflex is a global provider of medical technologies designed to improve the health and quality of people’s lives. We apply purpose driven innovation – a relentless pursuit of identifying unmet clinical needs – to benefit patients and healthcare providers. Our portfolio is diverse, with solutions in the fields of vascular and interventional access, surgical, anesthesia, cardiac care, urology, emergency medicine and respiratory care. Teleflex employees worldwide are united in the understanding that what we do every day makes a difference. For more information, please visit http://www.teleflex.com.

Teleflex is the home of Arrow®, Deknatel®, Hudson RCI®, LMA®, Pilling®, Rusch®, UroLift® and Weck® – trusted brands united by a common sense of purpose

# # #

For Teleflex Incorporated:

Jake Elguicze, 610.948.2836

Treasurer and Vice President, Investor Relations

Media:

Nicole Osmer, 650.454.0504 nicole@healthandcommerce.com

*No instances of new, sustained erectile or ejaculatory dysfunction

1. Roehrborn, J Urology 2013 LIFT Study

2.McVary, J Sex Med 2016

MAC00968-01 Rev A

Share article on social media or email:

AIM Appoints Masline Electronics as Distributor of Full Line of Solder Products


News Image

AIM Solder, a leading global manufacturer of solder assembly materials for the electronics industry, is pleased to announce the signing of Masline Electronics as its new distributor for its full line of products in the Northern New York market.

With experience in product distribution, logistics and service, Masline Electronics provides versatile customized solutions to improve efficiency and profits by balancing manufacturing challenges. Masline Electronics is the longest-running distributor of industry-leading passive and electromechanical components. An ISO 9000 Quality certified company, Masline Electronics offers services in lead forming, logistics, kitting, packaging, labeling and custom assembly.

For more information about Masline Electronics, please visit http://www.masline.com.

About AIM

Headquartered in Montreal, Canada, AIM Solder is a leading global manufacturer of assembly materials for the electronics industry with manufacturing, distribution and support facilities located throughout the world. AIM produces advanced solder products such as solder paste, liquid flux, cored wire, bar solder, epoxies, lead-free and halogen-free solder products, and specialty alloys such as indium and gold for a broad range of industries. A recipient of many prestigious SMT industry awards, AIM is strongly committed to innovative research and development of product and process improvement as well as providing customers with superior technical support, service and training. For more information about AIM’s complete line of advanced solder products and global technical services, please visit http://www.aimsolder.com.

Share article on social media or email:

Point of Care at the Forefront of COVID-19 Testing in Quest to Break Transmission Chain


Kalorama Information logo

To break a transmission chain, fast access is needed. These tools offer a tool for action, rather than waiting on texts and doctor’s office staff.

Demand for testing has gone from a healthcare industry topic to a national crusade in weeks with the onset of COVID-19. High-throughput tests have been approved by the U.S. Food and Drug Administration (FDA) for use in the U.S. for the detection of SARS-CoV-2, the virus behind the disease. But for true intervention in doctors offices — or even airports, many see so-called “point-of-care” (POC) IVD tests as the ideal solution.

A new report on worldwide point-of-care markets from IVD market researcher Kalorama Information has been released amid the coronavirus outbreak. The report has markets for all kinds of near-patient testing — everything from self-testing for glucose to rapid HIV tests to cardiac marker tests. Yet the focus in recent weeks has been on tests for COVID-19. Point-of-care tests are tests designed to be portable enough and fast enough to be useful during an office visit or in a decentralized location within a hospital or clinic.

“To break a transmission chain, fast access is needed. These tools offer a tool for action, rather than waiting on texts and doctor’s office staff,” said Bruce Carlson, publisher of Kalorama Information.

Kalorama publishes a report each year on POC markets and has just released its 2020 version: https://kaloramainformation.com/product/the-worldwide-market-for-point-of-care-poc-diagnostics-7th-edition/.

In terms of actual tests for coronavirus tests, there are no U.S. approvals at the time of writing, but products are in development. Molecular POC (mPOC) tests make the most sense because the threat is a virus and can be identified using the gold standard of reverse transcription polymerase chain reaction (RT-PCR). Point-of-care tests are currently used for flu and step tests, including systems by Abbott (ID NOW), Roche (Liat), and Cepheid (Xpert Xpress).

mPOC-maker Cepheid says it is developing an automated molecular test for the qualitative detection of SARS-CoV-2. And Cepheid says it will try to utilize its tens of thousands of existing instrument placements. “By leveraging the design principles of our current Xpert Xpress Flu/RSV cartridge technology, in which multiple regions of the viral genome are targeted to provide rapid detection of current and future pandemic coronavirus strains, we are developing a test that can be applied in multiple settings where actionable patient management information is needed quickly,” the company said.

Singapore POC maker Credo Diagnostics Biomedical announced this week that it has obtained the CE mark in Europe for an assay to detect SARS-CoV-2. The test runs on the firm’s platform, called VitaPCR, and the company said it uses PCR and runs the test in 20 minutes. The system needs minimal operator training to run and involves no additional equipment, according to Credo. The company says the VitaPCR SARS-CoV-2 Assay is now also pending Emergency Use Authorization from the FDA and Emergency Use Listing from the World Health Organization.

While not as fast as immunoassays, the mPOC systems typically use isothermal amplification to achieve much faster turnaround than the regular lab-based RT-PCR tests. This is one of their biggest strengths, along with low system cost and portability; however, these can often have a several-fold higher cost per sample compared with RT-PCR performed in a centralized lab due to the small proprietary systems requiring specific cartridges and consumables. The following are some additional examples of molecular diagnostic systems and assays including POC and other technologies which are available or under development:


  • Aldatu Biosciences – PANDAA qDx SARS-CoV-2
  • Becton Dickinson (BD) – BD and BioGX submitted for EUAs on BD Max platform- BGI/ Pathomics Health – Fluorescent RT-PCR kit (CE marked); 2019-nCoV PMseq Kit
  • Bio-Rad – standards – synthetic COVID-19 RNA transcripts and human genomic DNA
  • bioMerieux/ BioFire Defense – FilmArray, BioFire COVID-19 Test
  • Biomeme – Go Strips for COVID-19
  • BIONEER Corporation – AccuPower 2019-nCoV
  • Caspr Biotech – Phantom 1.0 Dx, disposable test usingCRISPR
  • Cepheid – Test in development for Xpert Xpress system announced; partnership for Sherlock Biosciences’ CRISPR-based SHERLOCK (Specific High-sensitivity Enzymatic Reporter unLOCKing) engineering biology platform, to design tests to run on Cepheid’s GeneXpert systems
  • CerTest Biotec – VIASURE 2019-nCoV Real Time PCR Kit (CE mark for BD Max platform)
  • Co-Diagnostics – Logix Smart Coronavirus Disease 2019 (COVID-19) Test; single step rRT-PCR (CE mark)
  • Coyote Bioscience – Mini8 Portable Molecular Diagnostic QPCR Station (CFDA approved)
  • Credo Diagnostics Biomedical – VitaPCR platform, COVID-19 assay (CE mark)
  • Curetis/ OpGen/ BGI – RTPCR test kit for SARS-CoV2 (CE mark)
  • Diagnostics for the Real World Ltd – SAMBA II COVID-19 Test
  • GenMark – ePlex SARS-CoV-2 test; sample-to-answer system based on competitive DNA hybridization and electrochemical detection technology (RUO, with EUA submitted)
  • HiberGene – HG Swift, can use battery power, pursuing Fast Track Emergency Use in China
  • Integrated DNA Technologies (Danaher) – 2019-nCoV CDC EUA Kit
  • Jiangsu Qitian Gene Biotechnology Co., Ltd. – Fluorescent RAA Detection for 2019-nCoV
  • LabCorp – COVID-19 reverse transcription polymerase chain reaction (RT-PCR) test (EUA issued)
  • LGC Biosearch – primer and probe kits for CDC Real-Time RT-PCR Diagnostic Panel
  • MiCo Biomed Co. Ltd – VERI-QTM PCR 316 COVID-19 detection system
  • Mobidiag – Novodiag COVID-19 + InfA/B – multiplex test for coronavirus and influenza
  • Molbio – TrueLab, Truenat SARS CoV-2 – TruePrep and TrueNAT instruments
  • Mologic – battery powered point-of-need diagnostic test
  • Novacyt – qPCR (CE mark)
  • OnSiteGene – Peak V
  • Pinpoint Science – SARS-Cov-2 test in partnership with Analog Devices
  • Qiagen – QIAstat-Dx, Respiratory Panel 2019-nCoV
  • QuantuMDx – Q-POC
  • RainSure Bio – DropX-2000 Digital PCR System, RainSure COVID-19 dPCR Detection Kit
  • Randox Laboratories Ltd – Extended Coronavirus Array
  • Seegene – Allplex 2019-nCoV assay (CE mark)
  • Sentinel Diagnostics – Stat-NAT COVID-19 assay
  • SolGent – DiaPlexQ Novel Coronavirus (2019-nCoV) Detection Kit (CE mark)
  • Twist Bioscience – NGS-based target capture for SARS-CoV-2 detection and screening
  • Ubiquitome – Liberty16, open mobile real time PCR system with 2-3 hour battery life

In addition to direct tests for SARS-CoV-2, Kalorama expects demand for flu tests to increase due to “rule-out” testing.

Right now, molecular is the focus for the current pandemic, but immunoassays also are in development. Molecular tests generally analyze the viral RNA in patient throat/nasal swabs, but there are other POC testing methods that use immunoassays to detect the patient’s COVID-19 antibodies in blood or serum. It appears there are roles for both mPOC and immunoassay POC tests as there are trade-offs between the two. Immunoassays generally suffer from a high rate of false negatives (low sensitivity), with some rare exceptions.

Nonetheless, immunoassays can have comparable specificity and a varying combination of lower cost, faster turnaround, greater portability, and, thus, advantages in the context of larger-scale population surveillance, screening, and triaging of patients in outbreak situations.

About Kalorama Information

For more than 30 years, Kalorama Information has been a leading publisher of market research in healthcare areas, including in vitro diagnostics (IVD), imaging, biotechnology, healthcare, medical devices, and pharmaceuticals.

Share article on social media or email:

New Alliance Academy Shares Data on Post-Graduation Student Success


New Alliance Academy, Paramus NJ students throwing their graduation caps in the air

The Therapeutic Education Program at New Alliance Academy Results in the Greater Likelihood of Students Pursuing Post-Secondary Education

“The programs offered at New Alliance Academy give our students a deeper understanding of themselves while setting them up for success on their journey to adulthood.” – New Alliance Academy Administration

New Alliance Academy provides its students with the life skills and tools needed to have a successful and productive life, as well as encourages those interested in pursuing tertiary studies to achieve their goal. One of the most frequently asked questions by parents and students is whether adolescents who attend the school have a good chance of progressing into college.

New Alliance Academy is proud to report that data collected over a 10 year period, show that the percentage of graduates who plan to attend a two or four year college is double the national average for students exiting similar schools.

About

New Alliance Academy in Paramus, NJ is a high school for teenagers who experience acute psychological distress. New Alliance Academy provides a full educational curriculum that addresses the emotional and academic needs of its students in a day school setting. The school integrates educational and ancillary therapeutic services, expertly crafted and delivered in one location. These therapeutic services are designed to eventually facilitate the adolescent’s return to a least restrictive educational setting as soon as they are ready. Students gain a deeper understanding of themselves by receiving the tools they need to move forward in their education and in life.

Share article on social media or email:

Paul Adkins’s newly released “Never A Dull Moment” is an evoking collection of poems that reflect a fulfilling life and an unwavering faith in God


News Image

“Never A Dull Moment”: an enriching tome of poems that exude with grace and insights on human life and the importance of godly belief. “Never A Dull Moment” is the creation of published author Paul Adkins, a dedicated writer of poems, a devoted follower of the Lord, and a former army officer.

Adkins shares, “The title says it all: ‘Never a Dull Moment.’ I hope everyone enjoys reading this book of poems. I also hope that you may like it and that there may not be a dull moment in your life. Just stay in Christ.”

Published by Christian Faith Publishing, Paul Adkins’s new book is a must-read for readers who seek to be enlightened with life’s meandering circumstances and further deepen their conviction in the Lord.

Readers will also partake in resounding original verses that will warm their hearts and fill them with wistfulness.

View the synopsis of “Never A Dull Moment” on YouTube.

Consumers can purchase “Never A Dull Moment” at traditional brick-and-mortar bookstores or online at Amazon.com, Apple iTunes store, or Barnes and Noble.

For additional information or inquiries about “Never A Dull Moment,” contact the Christian Faith Publishing media department at 866-554-0919.

Share article on social media or email: